Literature DB >> 20069391

Induction of cell size vesicles from human lymphoma cell lines and their application to drug carriers.

Makoto Yamanaka1, Shigeki Nakamura, Aiko Inoue, Takashi Yasuda, Yuichi Inoue, Hiroharu Kawahara.   

Abstract

Sodium butyrate (NaB) induced the membrane enclosed cell size vesicles from several IgM producing cell lines. We considered the application of the cell-derived vesicles (CDVs) to drug delivery system (DDS) using the lung cancer specific IgM producing AE6 cell line. Microscopic observation showed that the DiI fluorescence labeled AE6 vesicles were incorporated into the lung cancer cell line A549. The anticancer drug, actinomycin D (actD), contained in AE6 and Ramos vesicles decreased the A549 cell viability to 46 and 62% of control without actD, respectively. The cytotoxic effect in AE6 vesicles was superior to that in the Ramos vesicles that have the lung cancer non-specific IgM on their surfaces. However, the result of the Ramos vesicles suggests that the surface molecules other than IgM may interact with the A549 cells. In our method for vesicle production, more specific and abundant antibodies mounted vesicles can be generated by transfection of their genes into cells followed by NaB treatment. These suggest that the CDVs may be useful for the development of a drug carrier for DDS.

Entities:  

Year:  2010        PMID: 20069391      PMCID: PMC2978302          DOI: 10.1007/s10616-009-9248-2

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  14 in total

1.  Reconstitution of membrane proteins into liposomes.

Authors:  Jean-Louis Rigaud; Daniel Lévy
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

2.  A vesicle bioreactor as a step toward an artificial cell assembly.

Authors:  Vincent Noireaux; Albert Libchaber
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-10       Impact factor: 11.205

3.  In vitro immunization of human lymphocytes with human lung cancer cell line A549.

Authors:  H Kawahara; S Shirahata; H Tachibana; H Murakami
Journal:  Hum Antibodies Hybridomas       Date:  1992-01

4.  Efficient gene transfer into lymphoma cells using adenoviral vectors combined with lipofection.

Authors:  P Buttgereit; S Weineck; G Röpke; A Märten; K Brand; T Heinicke; W H Caselmann; D Huhn; I G Schmidt-Wolf
Journal:  Cancer Gene Ther       Date:  2000-08       Impact factor: 5.987

5.  Specific reactivity of human monoclonal antibody AE6F4 against cancer cells in tissues and sputa from lung cancer patients.

Authors:  M Shoji; S Kawamoto; S Sato; M Kamei; M Kato; S Hashizume; K Seki; K Yasumoto; A Nagashima; H Nakahashi
Journal:  Hum Antibodies Hybridomas       Date:  1994

6.  Giant liposome microreactors for controlled production of calcium phosphate crystals.

Authors:  Marc Michel; Mathias Winterhalter; Laurent Darbois; Joseph Hemmerle; Jean Claude Voegel; Pierre Schaaf; Vincent Ball
Journal:  Langmuir       Date:  2004-07-20       Impact factor: 3.882

7.  Human-human hybridomas secreting antibodies specific to human lung carcinoma.

Authors:  H Murakami; S Hashizume; H Ohashi; K Shinohara; K Yasumoto; K Nomoto; H Omura
Journal:  In Vitro Cell Dev Biol       Date:  1985-10

8.  Sodium butyrate stimulates monoclonal antibody over-expression in CHO cells by improving gene accessibility.

Authors:  Zhou Jiang; Susan T Sharfstein
Journal:  Biotechnol Bioeng       Date:  2008-05-01       Impact factor: 4.530

9.  Butyrate suppression of histone deacetylation leads to accumulation of multiacetylated forms of histones H3 and H4 and increased DNase I sensitivity of the associated DNA sequences.

Authors:  G Vidali; L C Boffa; E M Bradbury; V G Allfrey
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

Review 10.  Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential.

Authors:  Maria Laura Immordino; Franco Dosio; Luigi Cattel
Journal:  Int J Nanomedicine       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.